Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
clinical-study
Press Release
Jan 6, 2025
CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia
Read More
Press Release
Dec 16, 2024
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update
Read More
Press Release
Sep 27, 2024
POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP™
Read More
Press Release
May 7, 2024
Digexin’s® New Clinical Study Demonstrates Novel Brain-to-Gut Benefits
The study reaffirms Digexin's substantial benefits for GI health, mood, stress reduction, and quality of life while pointing to a novel brain-to-gut mechanism.
Read More
Press Release
Jul 14, 2023
POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial
Read More
Press Release
Mar 27, 2023
Spectral MD Announces U.S. Burn AI Clinical Training Study Enrollment Completion
Successful completion of clinical study enrollment paves way for next phase of BARDA funding. Data used to finalize DeepView AI®-Burn algorithm.
Read More
Press Release
Feb 21, 2023
Spectral MD Initiates EU Diabetic Foot Ulcer Clinical Study in Ireland
Data from the study to support regulatory submissions on track for 2023. Participation from distinguished EU principal investigators provides significant endorsement for DeepView™.
Read More
Press Release
Jul 19, 2022
Ecofibre and Ananda Professional Open Registration for CBD360
The Largest Clinical and Commercial Hemp and CBD Education Event
Read More
Press Release
Mar 7, 2022
Ananda Professional is Opening Enrollment to Participate in an IRB-Approved Phase IV Clinical Trial Investigating How CBD May Benefit Women's Health and Wellness
This study was created to help women Find Relief from Endometriosis and Exclusion (FREE HER). Its purpose is to help us learn how medications and other substances can reduce complaints of pelvic pain and related issues.
Read More
Press Release
Mar 3, 2022
OliLux Biosciences Kickstarts a Partnership With the UCSF Center for Tuberculosis and the Rapid Research in Diagnostics Development (R2D2) for TB Network
OliLux Biosciences is partnering with the R2D2 TB Network and the UCSF Center for Tuberculosis to clinically evaluate and advance its novel rapid detection technology for drug-resistant tuberculosis.
Read More
Press Release
Feb 3, 2022
Faro Health Inc. Expands Leadership Team and Announces Participation at SCOPE, Following Its $15 Million Series A Funding
● Faro Health Inc. strengthens its management team, appointing Kimberly C. Pospahala as Vice President of Commercial to accelerate go-to-market efforts to digitally transform clinical protocol design ● Scott Chetham, Ph.D., Co-Founder & CEO of Faro Health, Inc., will present at the SCOPE Conference on Feb. 9, 2022
Read More
Press Release
Dec 6, 2021
Appointment of Spectral MD Chief Financial Officer
Former KCI (Acelity), 3M and Siemens Healthcare Vice President Nils Windler joins Spectral MD
Read More
Press Release
Nov 30, 2021
Enrollment Completed for Multi-Center Study for Diabetic Foot Ulcers ('DFU')
Data being collected from 150 adult subjects to further develop DeepView® DFU application
Read More
Press Release
Nov 23, 2021
Spectral MD's DeepView® Burn AI Clinical Study Results Presented at Southern Region Burn Conference
92% for adults and 88% for pediatric accuracies reported on 124 subject multi-center clinical study
Read More
Press Release
Nov 4, 2021
Enalare Therapeutics Announces First Subject Dosed With Lead Product ENA-001 in a Propofol-Induced Respiratory Depression Study
Read More
Press Release
Sep 27, 2021
RIVANNA's Accuro Shows Statistically Significant Efficacy and Safety for Combined Spinal-Epidural Anesthesia
Read More
Press Release
Jun 8, 2021
FDA Grants Coordination Pharmaceuticals IND Approval for CPI-300, a Novel Antitumor Nanomedicine
Read More
Press Release
Jun 8, 2021
Faro Health Inc. Secures $15 Million Series A Financing to Deliver Digital Transformation for Clinical Study Design and Authoring
Read More
Press Release
Jan 13, 2021
Philogen Announces the Completion of a Second Interim Analysis of Its Phase III Clinical Program With Nidlegy for the Treatment of Melanoma
Nidlegy was found to be well-tolerated and 149 out of the anticipated 214 patients have been safely treated. Data Safety Monitoring Board recommends to continue the study as planned.
Read More
Press Release
Aug 8, 2019
Coordination Pharmaceuticals Announces Enrollment of the First Patient in Phase 1 Study of CPI-200 in Patients With Advanced Tumors
Read More
Press Release
Oct 5, 2018
FDA Grants Coordination Pharmaceuticals IND Approval for CPI-100, a Novel Antitumor Nanomedicine
Read More
Press Release
Oct 2, 2018
Interventional vs. Non-Interventional: Considerations for Correctly Classifying Your Clinical Study, New Webinar Hosted by Xtalks
Read More
Press Release
Sep 17, 2018
Decoding eClinical Software: CTMS Evaluation for the Non-IT Professional, New Webinar Hosted by Xtalks
Read More
Press Release
Sep 17, 2018
Configuration in ePRO: Making Design More Collaborative and Delivering Better Results, New Webinar Hosted by Xtalks
Read More
Press Release
May 1, 2018
Innovation in ePRO for Questionnaire Data Capture, New Webinar Hosted by Xtalks
Read More
Press Release
Apr 3, 2018
BYOD for ePRO Study Results: Addressing Risks & Leveraging Benefits, New Webinar Hosted by Xtalks
Bring your own device (BYOD) solutions offer a disruptive alternative to the costly provisioned solutions for ePRO but have been mostly overlooked and only moderately considered due, in part, to this question of equivalence and to concerns for patients accepting study tools on their own phones.
Read More
Press Release
Mar 19, 2018
New Tufts Study: Assessing CRO Oversight Effectiveness and Impact, New Webinar Hosted by Xtalks
Experts from Comprehend and Tufts CSDD to discuss the recent study, outline where the industry is headed and ways to overcome oversight challenges including transparency, risk, and compliance
Read More
First
Prev
1
Next
Last